Navigation Links
Takeda's Antibody Therapeutics Research Company, Takeda San Francisco, Inc. Appoints Mary Haak-Frendscho, Ph.D. as President and CSO
Date:5/22/2008

SAN FRANCISCO, May 22 /PRNewswire/ -- Takeda San Francisco Inc. announced today the appointment of Mary Haak-Frendscho, Ph.D., as president and chief scientific officer. Dr. Haak-Frendscho will be responsible for leading all activities at Takeda San Francisco including overall research and preclinical development, process development studies and operations for antibody therapeutics.

Takeda San Francisco is a wholly owned subsidiary of Takeda Pharmaceutical Company Limited of Osaka, Japan ("Takeda").

"Dr. Haak-Frendscho's strong leadership skills and biotechnology experience will greatly contribute to the success of Takeda San Francisco," said Shigenori Ohkawa, Ph.D., general manager, pharmaceutical research division, Takeda. "Takeda San Francisco will play an increasingly critical role in the expansion of Takeda's R&D capabilities as we look to promote the development of antibody therapeutics, and I am confident that Dr. Haak-Frendscho will help us realize our goals in the antibody field."

With more than 17 years of pharmaceutical and biotechnology experience, Dr. Haak-Frendscho has held positions at Genentech, Abgenix and most recently, at XOMA, where she served as chief science officer and vice president, preclinical research and development.

"I feel honored to join Takeda San Francisco," said Dr. Haak-Frendscho. "My background in biotechnology coupled with Takeda San Francisco's impressive existing antibody research is a natural fit, and will help realize Takeda's plan of creating new drugs through in-house R&D activities. I look forward to working with Takeda San Francisco's talented team to develop products that will improve the lives of patients."

Dr. Haak-Frendscho conducted post-doctorate work at the department of immunology, Genentech Inc., in preclinical in vitro and in vivo research and development of a humanized mAb therapeutic product candidate MaE11/MaE25 (Xolair(R)). She holds a doctorate in immunology from th
'/>"/>

SOURCE Takeda Pharmaceutical Company Limited
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. EUSA Pharma Divests Monoclonal Antibody Research Business and Early-Stage Oncology Product
2. ARIUS presents new findings for anti-cancer antibody programs at AACR
3. Monogram HIV Antibody Assay Is Key Component of Innovative Vaccine Development Program
4. Antibody Engineering Company F-Star Buys Back Royalty Obligations
5. Genmab and PDL BioPharma Close Sale of Antibody Manufacturing Facility
6. Antibody Engineering Company f-Star Opens Second Research Site in Cambridge, UK
7. John E. Leonard, Ph.D., Former Biogen Idec Antibody Development Executive, Joins the Scientific Advisory Board of Vaccinex, Inc.
8. Purchase Agreement for Antibody Manufacturing Facility Receives Antitrust Clearance
9. ESBATechs Antibody Fragments Demonstrate Penetration into the Eye with Topical Delivery via Eye Drops
10. Genmab and PDL BioPharma Sign Purchase Agreement for Antibody Manufacturing Facility
11. Vaccinex Antibody Licensed to GlaxoSmithKline
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... (PRWEB) December 17, 2014 Based ... the overall surgical imaging market is dominated by ... the surgical imaging market. These players include GE ... Ziehm Imaging (Germany). , Full Report Copy ... of GE Healthcare can be attributed to its ...
(Date:12/17/2014)... CA (PRWEB) December 17, 2014 Once ... to provide a larger packaged waste water treatment plant ... King Abdullah Economic City (KAEC). Two years ago Bioshaft ... Jeddah Gate Development, serving two residential towers with an ... is over a quarter million gallons per day and ...
(Date:12/17/2014)... San Diego, CA (PRWEB) December 17, 2014 ... strategy and activation agency and member of the Huntsworth ... Jamie Gonzales to its executive team. In her role, ... Services. , “We are incredibly honored to welcome ... said Agency Chief and CEO, Gaëtan Fraikin. “She is ...
(Date:12/17/2014)... , Dec. 17, 2014 Tigercat ... Phase 2 study evaluating the investigational oral NK-1 ... patients with severe, chronic itch who are unresponsive ... care, including topical steroids and antihistamines. ... in Visual Analog Scale (VAS) itch score from ...
Breaking Biology Technology:Global Refurbished Surgical Imaging Market by Product & Application is Estimated to Reach $1.25 Billion by 2019 - New Research Report by MarketsandMarkets 2Global Refurbished Surgical Imaging Market by Product & Application is Estimated to Reach $1.25 Billion by 2019 - New Research Report by MarketsandMarkets 3Global Refurbished Surgical Imaging Market by Product & Application is Estimated to Reach $1.25 Billion by 2019 - New Research Report by MarketsandMarkets 4Audacity Welcomes Healthcare Communications Expert Jamie Gonzales as Senior Vice President of Client Services 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 3Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 4
... at the American Society of Clinical Oncology (ASCO) annual meeting, ... Today at 5:00 p.m. Eastern Time - REDWOOD CITY, Calif., ... ) today announced that the QUASAR validation study met ... stage II colon cancer patients following surgery, and that the ...
... at 2:00 p.m. PT (5:00 p.m. ET)IRVINE, Calif., April 14 ... of Pulse CO-Oximetry and Measure-Through Motion and Low-Perfusion pulse oximetry, ... for the period ended April 4, 2009 after the market ... the results will begin at 2:00 p.m. PT (5:00 p.m. ...
... and New Vice President of Healthcare Brings 22 ... Ore., April 14 Prolifiq Software, Inc., today ... company as vice president of healthcare. In this ... mobile email messaging services for sales representatives in ...
Cached Biology Technology:Genomic Health Announces Positive Preliminary Results from QUASAR Validation Study of Oncotype DX(R) Colon Cancer Assay 2Genomic Health Announces Positive Preliminary Results from QUASAR Validation Study of Oncotype DX(R) Colon Cancer Assay 3Genomic Health Announces Positive Preliminary Results from QUASAR Validation Study of Oncotype DX(R) Colon Cancer Assay 4Masimo to Report First Quarter 2009 Financial Results on May 5, 2009 2Masimo to Report First Quarter 2009 Financial Results on May 5, 2009 3Prolifiq Further Expands Into Medical Markets With New Hire Maureen A. Shaffer 2Prolifiq Further Expands Into Medical Markets With New Hire Maureen A. Shaffer 3
(Date:12/5/2014)... VIEW, Calif. , Dec. 4, 2014 /PRNewswire/ ... safety has boosted investments in new testing and ... has also given rise to a range of ... by the requirements of Generation Y, which is ... technologies. As a result, product development strategies of ...
(Date:11/21/2014)... According to a new market ... RFID, Access Control, Intrusion Detection, Parking Management, Under Vehicle ... Service Geography - Global Forecasts to 2020", published by ... be around $25 Billion in 2014 and is expected ... CAGR of 8.69%. Browse 116 market data ...
(Date:11/18/2014)... 18, 2014  The Secure Identity & Biometrics ... jointly announce the formation of The Airport Entry ... Identity and Biometric Entry and Exit Solutions ... official support from BORDERPOL, the international non-profit organization ... provide expertise regarding border security, traveler and migration ...
Breaking Biology News(10 mins):Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 3Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 4Industrial Security Systems Market Worth $38 Billion by 2020 2Industrial Security Systems Market Worth $38 Billion by 2020 3Identity Management, Document Authentication and Biometric Companies Form "The Airport Entry and Exit Working Group", Releasing the Framework to Help Guide the Department of Homeland Security and Congress Towards Solutions 2Identity Management, Document Authentication and Biometric Companies Form "The Airport Entry and Exit Working Group", Releasing the Framework to Help Guide the Department of Homeland Security and Congress Towards Solutions 3
... most school children understand that green plants photosynthesize, ... consider the profound global-scale effects that photosynthesis has ... light on the origins and evolution of photosynthesis ... University,s School of Life Sciences. Oxygen, one ...
... CLEVELAND Case Western Reserve University has granted ... regarding a portfolio of insulin analogs. The company must ... to obtain an exclusive license on therapies designed to ... developing treatments that it hopes will become an important ...
... discoveries about the deep ocean,s temperature variability and circulation ... The deep ocean is affected more by surface ... more accurate predictions of factors such as sea level ... temperatures have also been found to result in a ...
Cached Biology News:'Extreme' genes shed light on origins of photosynthesis 2'Extreme' genes shed light on origins of photosynthesis 3Case Western Reserve University grants option to startup Thermalin Diabetes Inc. 2New discoveries could improve climate projections 2
ID clarifier: platform...
The sealed ice cooling unit is used to absorb heat that is generated during transfers performed in the Criterion blotter....
... Tetrad 2 thermal cycler accommodates a ... heat-pump assemblies), which hold different types ... computer drives an advanced graphical interface ... lid temperatures. Peltier heat pumps, built ...
The SVT3-2 diverter valve is a 3-port, 2-position valve for use with the BioLogic DuoFlow system....
Biology Products: